• Exchange: Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

KARO:SS

0.8750 SEK 0.0250 2.94%

As of 06:10:32 ET on 07/28/2014.

Snapshot for Karo Bio AB (KARO)

Open: 0.8600 Day's Range: 0.8500 - 0.8750 Volume: 911,825
Previous Close: 0.8500 52wk Range: 0.2466 - 1.1300 1-Yr Rtn: +210.00%

Stock Chart for KARO

No chart data available.
  • KARO:SS 0.8750
  • 1D
  • 1M
  • 1Y
0.8500
Interactive KARO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for KARO

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 19.7674
Relative P/E vs. OMX -
Earnings Per Share (SEK) (ttm) -0.0500
Est. EPS (SEK) (12/2014) 0.0430
Est. PEG Ratio -
Market Cap (M SEK) 574.82
Shares Outstanding (M) 676.26
30 Day Average Volume 2,575,789
Price/Book (mrq) 8.1044
Price/Sale (ttm) 12.9692
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/24/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for KARO

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for KARO

Karo Bio AB operates a drug research and development company. The Company develops precision drugs to treat major diseases in the field of nuclear receptors. Karo Bio works within many therapeutic areas including men and women's health, cardiovascular diseases, metabolic disorders and dermatology.

Per BengtssonPresident/CEOHenrik PalmChief Financial Officer
Maria SjoebergVP/Chief Scientific OfficerMark FarmeryHead:Business Development
More Company Profile & Key Executives for KARO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil